Related references
Note: Only part of the references are listed.2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks et al.
EUROPEAN HEART JOURNAL (2021)
Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients
Wengen Zhu et al.
STROKE (2021)
Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies
Linxin Li et al.
LANCET NEUROLOGY (2021)
Canadian stroke best practice recommendations: Management of Spontaneous Intracerebral Hemorrhage, 7th Edition Update 2020
Ashkan Shoamanesh et al.
INTERNATIONAL JOURNAL OF STROKE (2021)
Risk of Arterial Ischemic Events After Intracerebral Hemorrhage
Santosh B. Murthy et al.
STROKE (2020)
Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adults
Yiping Chen et al.
Lancet Global Health (2020)
Long-term prognosis after intracerebral haemorrhage
Koen M. van Nieuwenhuizen et al.
EUROPEAN STROKE JOURNAL (2020)
STudy of Antithrombotic Treatment after IntraCerebral Haemorrhage: Protocol for a randomised controlled trial
Kristin Tveitan Larsen et al.
EUROPEAN STROKE JOURNAL (2020)
Five-Year Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage
Barbara Casolla et al.
STROKE (2019)
Intracerebral Haemorrhage Segmentation in Non-Contrast CT
Ajay Patel et al.
SCIENTIFIC REPORTS (2019)
Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline
Catharina J. M. Klijn et al.
EUROPEAN STROKE JOURNAL (2019)
The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study
Mark A. Rodrigues et al.
LANCET NEUROLOGY (2018)
Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts
Yan Xu et al.
PLOS ONE (2018)
Cerebral White Matter Hypoperfusion Increases with Small-Vessel Disease Burden. Data From the Third International Stroke Trial
Francesco Arba et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)
Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation
Eleni Korompoki et al.
NEUROLOGY (2017)
Restarting Anticoagulant Therapy After Intracranial Hemorrhage A Systematic Review and Meta-Analysis
Santosh B. Murthy et al.
STROKE (2017)
Cerebral White Matter Hypoperfusion Increases with Small-Vessel Disease Burden. Data From the Third International Stroke Trial
Francesco Arba et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)
Oral Anticoagulation and Functional Outcome after Intracerebral Hemorrhage
Alessandro Biffi et al.
ANNALS OF NEUROLOGY (2017)
Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage
Tze-Fan Chao et al.
CIRCULATION (2016)
Anticoagulant Reversal, Blood Pressure Levels, and Anticoagulant Resumption in Patients With Anticoagulation-Related Intracerebral Hemorrhage
Joji B. Kuramatsu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial
Koen M. van Nieuwenhuizen et al.
TRIALS (2015)
Variation in Restarting Antithrombotic Drugs at Hospital Discharge After Intracerebral Hemorrhage
Marta Pasquini et al.
STROKE (2014)
Impact of double-blind vs. open study design on the observed treatment effects of new oral anticoagulants in atrial fibrillation: a meta-analysis
J. -C. Lega et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal
David M. Kent et al.
TRIALS (2010)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
LANCET (2009)
Share Paper
